Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease

Curr Opin Neurobiol. 2018 Aug;51:134-138. doi: 10.1016/j.conb.2018.04.027. Epub 2018 May 10.

Abstract

The accumulation of pathological tau in the brain is associated with neuronal deterioration and cognitive impairments in tauopathies including Alzheimer's disease. Tau, while primarily localized in the axons of healthy neurons, accumulates in the soma and dendrites of neurons under pathogenic conditions. Tau is found in both presynaptic and postsynaptic compartments of neurons in Alzheimer's disease. New research supports that soluble forms of tau trigger pathophysiology in the brain by altering properties of synaptic and neuronal function at the early stages of disease progression, before neurons die. Here we review the current understanding of how tau-mediated synaptic and neuronal dysfunction contributes to cognitive decline. Delineating the mechanisms by which pathogenic tau alters synapses, dendrites and axons will help lay the foundation for new strategies that can restore neuronal function in tauopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Neurodegenerative Diseases / pathology*
  • Neurons / metabolism*
  • Neurons / pathology*
  • Synapses / metabolism*
  • tau Proteins / metabolism*

Substances

  • tau Proteins